Prophylaxis for hemophilia: State of the art or state of confusion?

Journal of Pediatrics

Volumn 132, Issue 6, 1998, Pages 915-917

  Gruppo, R A ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9;

ARTHROPATHY; BLEEDING; CLINICAL TRIAL; COST; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; EDITORIAL; HEMOPHILIA; HUMAN; INFUSION; PRIORITY JOURNAL; PROPHYLAXIS; TREATMENT OUTCOME;

EID: 0031812216     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(98)70382-8     Document Type: Editorial

References (22)

1. PH Levine Efficacy of self-therapy in hemophilia: a study of 72 patients with hemophilia A and B N Engl J Med 291 1974 1381 1384
2. WD Arnold MW Hilgartner J Bone Joint Surg Am 59A 1977 287 305
3. MJ Manco-Johnson R Nuss S Geraghty S Funk R Kilcoyne Results of secondary prophylaxis in children with severe hemophilia Am J Hematol 47 1994 113 117
4. IM Nilsson E Berntorp T Löfqvist H Pettersson Twenty-five years’ experience of prophylactic treatment in severe haemophilia A and B J Intern Med 232 1992 25 32
5. W Schramm Experience with prophylaxis in Germany Semin Hematol 30 suppl 2 1993 12 15
6. LM Aledort RH Haschmeyer H Pettersson Orthopaedic Outcome Study Group A longitudinal study of orthopaedic outcomes for severe factor VIII-deficient haemophiliacs J Intern Med 236 1994 391 399
7. HM Van den Berg HK Nieuwenhuis EP Mauser-Bunschoten G Roosendaal Hemophilia prophylaxis in the Netherlands Semin Hematol 31 suppl 2 1994 13 15
8. RJ Liesner K Khair IM Hann The impact of prophylactic treatment on children with severe haemophilia Br J Haematol 92 1996 973 978
9. T Löfqvist IM Nilsson E Berntorp H Pettersson Haemophilia prophylaxis in young patients: a long-term follow-up J Intern Med 241 1997 395 400
10. The National Hemophilia Foundation Medical and Scientific Advisory Council (MASAC) recommendations concerning prophylaxis March 11, 1994 The National Hemophilia Foundation (110 Greene St., N.Y., N.Y. 10012) Medical Bulletin No. 193, Chapter Advisory No. 197
11. LM Aledort RL Bohn Prophylaxis and continuous infusion for hemophilia: Can we afford it? Blood Coagul Fibrinolysis 7 suppl 1 1996 S35 S37
12. E Berntorp Methods of haemophilia care delivery: regular prophylaxis versus episodic treatment Haemophilia 1 suppl 1 1995 3 7
13. JM Lusher Prophylaxis in children with hemophilia: is it the optimal treatment? Thromb Haemost 78 1997 726 729
14. PS Smith SM Teutsch PA Shaffer H Rolka B Evatt Episodic versus prophylactic infusions for hemophilia A: a cost-effectiveness analysis J Pediatr 129 1996 424 431
15. R Bohn J Avorn Cost-effectiveness: Can it be measured? Semin Hematol 30 suppl 2 1993 20 23
16. J Cooke Pharmacoeconomics of haemophilia Blood Coagul Fibrinol 8 suppl 1 1997 S41 S44
17. M Carlsson E Berntorp S Björkman K Lindvall Pharmacokinetic dosing in prophylactic treatment of hemophilia A Eur J Haematol 51 1993 247 252
18. M Carlsson E Berntorp S Björkman S Lethagen R Ljung Improved cost-effectiveness by pharmacokinetic dosing of factor VIII in prophylactic treatment of haemophilia A Haemophilia 3 1997 96 101
19. E Berntorp Prophylaxis for hemophilia Int J Pediatr Hematol Oncol 1 1994 463 470
20. K Miller GR Buchanan S Zappa C Cochran J Laufenberg D Medeiros Implantable venous access devices in children with hemophilia: a report of low infection rates J Pediatr 132 1998 934 938
21. MV Ragni JD Hord J Blatt Central venous catheter infection in haemophiliacs undergoing prophylaxis or immune tolerance with clotting factor concentrate Haemophilia 3 1997 90 95
22. I Warrier K Baird-Cox JM Lusher Use of central venous catheters in children with haemophilia: one haemophilia treatment centre experience Haemophilia 3 1997 194 198